본문 바로가기(Skip Contents)
ENGLISH
KOREAN
HOME
ABOUT US
Overview
History
Manufacturing facility
Our Company
PRODUCT
ALS (NeuroNata-R®)
Lou Gehrig's disease
PIPELINE
Pipeline
SLE
CA
R&D
Stem Cell Therapy
IR
Stock Information
Disclosures
Finances
Announcement of Settlement
IR Inquiry
PR
Press Report
Notice
Media
Online Inquiry
전체메뉴
전체메뉴
ABOUT US
Overview
History
Manufacturing facility
Our Company
PRODUCT
ALS (NeuroNata-R®)
Lou Gehrig's disease
PIPELINE
Pipeline
SLE
CA
R&D
Stem Cell Therapy
IR
Stock Information
Disclosures
Finances
Announcement of Settlement
IR Inquiry
PR
Press Report
Notice
Media
Online Inquiry
HOME
ENGLISH
KOREAN
ABOUT US
Overview
History
Manufacturing facility
Our Company
PRODUCT
ALS (NeuroNata-R®)
Lou Gehrig's disease
PIPELINE
Pipeline
Target Disease
Lupus
R&D
Stem Cell Therapy
IR
Stock Information
Disclosures
Finances
Announcement of Settlement
IR Inquiry
PR
Press Report
Notice
Media
Online Inquiry
PR
Corestem is a biopharmaceutical company that
researches and commercializes stem cell technology.
Press Report
Notice
Media
Online Inquiry
Press Report
Notice
Media
Online Inquiry
공지사항
16
2022.08
합병 공시 관련 주주서한 전달
READ MORE
11
2022.07
뉴로나타-알주 가격인상 안내문
READ MORE
30
2022.06
혁신형 제약 인증 관련 안내의 건
READ MORE
17
2022.05
IR 대표전화 운영방침의 건
READ MORE
28
2022.03
내부정보관련 규정 공지
READ MORE
1
2
3
4